Abbott Laboratories Earnings
NYSE: ABTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Next earnings date
Wed, Oct 21, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$1.42
Abbott Laboratories earnings summary
Abbott Laboratories is scheduled to report Sep/2026 earnings on Oct 21, 2026 before the market opens, with analysts expecting EPS of $1.42. In its most recent report on Apr 29, 2026 (Q1 2026), ABT posted EPS of $0.61. Revenue for the quarter was $11.16 billion.
Quarterly EPS is down 19.7% from the same quarter a year earlier. Across the last 16 reports, ABT shares moved an average of 3.0% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
ABT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Apr 29, 2026 | — | $0.61 | — | -5.7% |
| Feb 20, 2026 | — | $1.01 | — | +3.7% |
| Oct 29, 2025 | — | $0.94 | — | +2.2% |
| Jul 30, 2025 | — | $1.01 | — | +5.5% |
| Apr 30, 2025 | — | $0.76 | — | +0.3% |
| Feb 21, 2025 | — | $5.26 | — | +2.3% |
| Oct 31, 2024 | — | $0.94 | — | -1.7% |
| Jul 31, 2024 | — | $0.74 | — | -2.3% |
| May 2, 2024 | — | $0.70 | — | -1.1% |
| Feb 16, 2024 | — | $0.91 | — | +4.8% |
| Nov 1, 2023 | — | $0.82 | — | -2.0% |
| Aug 3, 2023 | — | $0.78 | — | -2.2% |
| May 4, 2023 | — | $0.75 | — | -0.7% |
| Feb 17, 2023 | — | $0.59 | — | -5.9% |
| Nov 1, 2022 | — | $0.81 | — | +6.1% |
| Aug 2, 2022 | — | $1.14 | — | +2.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.